These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 15196869

  • 1. Endobronchial clear cell adenocarcinoma occurring in a patient 15 years after treatment for DES-associated vaginal clear cell adenocarcinoma.
    Hall WB, Detterbeck FC, Livasy CA, Fowler WC.
    Gynecol Oncol; 2004 Jun; 93(3):708-10. PubMed ID: 15196869
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG, Michael H, Hodel KA.
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
    Clement R, Guilbaud E, Barrios L, Rougé-Maillart C, Jousset N, Rodat O.
    Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
    [Abstract] [Full Text] [Related]

  • 13. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
    Herbst AL.
    Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
    [No Abstract] [Full Text] [Related]

  • 14. Cytologic examination to detect clear cell adenocarcinoma of the vagina or cervix.
    Hanselaar AG, Boss EA, Massuger LF, Bernheim JL.
    Gynecol Oncol; 1999 Dec; 75(3):338-44. PubMed ID: 10600286
    [Abstract] [Full Text] [Related]

  • 15. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA.
    Int J Fertil; 1989 Dec; 34(4):251-5. PubMed ID: 2570761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors for diethylstilbestrol-associated clear cell adenocarcinoma.
    Palmer JR, Anderson D, Helmrich SP, Herbst AL.
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):814-20. PubMed ID: 10831973
    [Abstract] [Full Text] [Related]

  • 18. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE, Bronz L, Wyss-Bernet M, Genton CY.
    Schweiz Med Wochenschr; 1985 Nov 02; 115(44):1555-61. PubMed ID: 3841230
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Delayed onset of clear cell adenocarcinoma of the vagina in DES-exposed progeny.
    Veridiano NP, Tancer ML, Delke I, Gal D, Giannattasio C.
    Obstet Gynecol; 1981 Mar 02; 57(3):395-8. PubMed ID: 7465156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.